Form D · Other Technology

ORAYA THERAPEUTICS INC

Newark, CA · CIK 0001395387

Offering snapshot reported May 13, 2014 · SEC filing

Reported sold
$25.1M
Offering amount: $38.2M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 28, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 13, 2014Initial$25,132,051No comparison5SEC filing
Apr 5, 2011Amendment$20,875,000$15,875,000vs Dec 29, 20107SEC filing
Dec 29, 2010Initial$5,000,000No comparison7SEC filing
Jul 22, 2009Initial$20,875,000No comparison7SEC filing
Apr 23, 2009Initial$3,000,030No comparisonNot reportedSEC filing
Dec 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Mar 30, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-217228
The actual Total Offering Amount was $38,232,005.54 and Total Amount Sold was $25,132,050.33
Series 1 Preferred Stock

Source: Form D, filed May 13, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Brooks Director
Peter Cohn Executive
Michael Gertner Director
Brian Halak Director
Guido Neels Director
John Onopchenko Director
James Taylor Director, Executive
Reza Zadno Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
8000 Jarvis Avenue Building 5
Newark, CA, 94560